LinkedIn Outreach for Indian Pharmaceutical Manufacturers: The 3-Touch Sequence (2026)

LinkedIn Outreach for Indian Pharmaceutical Manufacturers: The 3-Touch Sequence (2026)

Quick Answer: Once you’ve built a list of Indian pharmaceutical manufacturers, Origami lets you run the entire LinkedIn outreach campaign from the same platform—no exporting CSVs, no separate sequencer. Origami now includes a built-in LinkedIn sequencer on all paid plans. In this guide, I’ll show you exactly how to refine that list, drop in a proven 3-touch sequence with actual copy you can steal, and send everything from Origami.

If you haven’t built your list yet, start with my guide on how to build a list of Indian pharmaceutical manufacturers. It walks you through using Origami’s AI agent to describe your ideal customer in plain English and get back a qualified, enriched prospect list. Once you have that list, come back here.

---

Step 1: Segment your list for better replies

Origami will already filter out junk, but for LinkedIn outreach to Indian pharma manufacturers, I always segment manually before firing. Pull up your list inside Origami and I recommend splitting contacts into three buckets:

• API / bulk drug manufacturers – decision-makers like Procurement Heads, Plant Managers, and R&D leads who deal with raw material sourcing, regulatory certifications (CDSCO, WHO‑GMP, USFDA), and cost pressures. Their pain points: inconsistent API quality, supplier audit fatigue, and fragile Chinese supply chains.
• Finished dosage form (FDF) manufacturers – Production Directors, QC/QA Managers, and Supply Chain Leads. They care about excipient consistency, packaging material lead times, and documentation for every single batch.
• Contract manufacturing organisations (CMOs) – Business Development or Operations heads. They’re often selling capacity, but also buying APIs and packaging; their world is timeline‑driven and they need suppliers who can scale without hiccups.

What “qualified” looks like for this audience: the person can say “yes” or introduce you to the person who can. Typically that’s someone with “Procurement,” “Supply Chain,” “QA,” “Plant,” or “R&D” in their title. If Origami returned a generic “Director” or “Manager” without department, I quickly search their LinkedIn headline—if it doesn’t hint at pharma manufacturing, I move them to a “maybe” pile and only reach out if I’m getting strong responses on primary contacts.

While you’re segmenting, make a note of any enriched details Origami surfaced—tools in their tech stack, recent news, or certifications. You’ll use these in your messages.

---

Step 2: Create a 3‑touch LinkedIn sequence (exact copy you can paste)

Origami gives you two ways to build the sequence. On the campaign setup screen inside Origami, you can either paste your own templates or ask the AI agent to write a personalized sequence for every lead. I’ve done both. For Indian pharma, I get better control by writing the templates myself and letting Origami automatically pull in first‑name and company variables. Here’s the exact 3‑touch sequence I run after someone accepts your connection request.

Touch 1 – Day 1: Connection request note

(Sent when you invite them. Character limit is 300, so I keep it under 100 words.)

Hi [First Name], I help Indian pharma manufacturers secure consistent API and excipient supplies without the compliance headaches. I saw your facility’s recent push into regulated markets—impressive. I’d love to connect and share a few sourcing approaches that have cut lead times for plants similar to yours. No pitch, just a genuine exchange.

Why it works: It shows you’ve done your homework (regulated markets = USFDA/EMA/CDSCO), names a specific pain point (supply consistency, lead times), and lowers the ask to a simple connection.

Touch 2 – Day 3: Value‑add follow‑up

(Sent only if they accept but don’t reply to your thank‑you message, if you send one. I skip the thank‑you and go straight to value.)

Hi [First Name], thanks for connecting. One quick thought: I’ve been working with a few mid-sized Indian pharma companies that reduced their API sourcing costs by ~12% while improving batch consistency. The trick was a qualification framework that shortened supplier audits by half. If that sounds relevant, I’d be happy to spend 15 minutes on a call this week—no attachment, just practical swaps. Let me know.

Why it works: It’s specific (12%, half the audit time), references a concrete framework without giving it all away, and offers a 15‑minute call that respects their time.

Touch 3 – Day 7: Soft close

Hi [First Name], last message—I know your time is valuable. If navigating the shift away from Chinese APIs, excipient shortages, or stricter EU GMP audits is on your radar this quarter, I’ve got a few insights that might help. If not, absolutely no worries. I appreciate the connection either way.

Why it works: It names the biggest anxieties in Indian pharma right now (China alternatives, shortages, audit pressure), and the soft exit keeps the door open without burning the contact.

Option B: Let Origami’s AI agent write it

If you prefer, simply toggle the “Agent‑written” option in Origami when you set up the sequence. The AI will read each lead’s enriched profile—job title, company focus, industry tools—and generate a unique 3‑touch sequence per person. I still recommend reviewing a sample to make sure the tone matches your brand, but it’s a huge time‑saver when you’re working with a list of 200+ contacts.

---

Step 3: Send the sequence directly from Origami

Here’s where Origami shines. Once you’ve pasted your templates (or chosen the agent), you set the delays between messages—I use Day 1, Day 3, Day 7—and hit “Launch.” No exporting CSVs, no connecting a third‑party sequencer. The built‑in LinkedIn sequencer starts sending connection requests and then automatically follows up with your templates at the intervals you configured.

Tracking & context: In the same Origami dashboard where you built your list, you can now see opens, clicks, and replies for every contact. What I love is the “Prospect context” panel—while looking at a contact’s activity, you still see their enriched profile (title, company, tools used) so you remember exactly why you reached out. If someone replies, they’re instantly un‑enrolled from the sequence—no more accidentally sending a breakup message after they’ve already booked a meeting.

Cost: The sequencer is included on all paid plans. You pay only for the credits used to enrich your leads. Outbound sending is free.

Expected results for Indian pharma manufacturers

This is a niche where decision‑makers are on LinkedIn but aren’t drowning in outreach the way SaaS executives are. From my campaigns, I see:

• Connection acceptance: 25–40% when the note is personalized to their facility or certification.
• Reply rate on follow‑ups: 8–12% if the list is well‑segmented.
• Meeting rate: about 3–5% of total contacted, which is solid for manufacturing.

If reply rates are below 5% after the first two weeks, check two things:

1. Are you reaching too many generic “Director” titles without clarity? Tighten your list.
2. Is the messaging touching a pain they actually feel? Make the opener even more specific—reference a regulation or a raw material shortage hitting their region.

---

Start with Origami’s free plan

You can build your first list of Indian pharmaceutical manufacturers on Origami’s free plan (1,000 credits, no credit card). The LinkedIn sequencer comes with every paid plan, starting at $29/month. That means you can go from plain‑English prompt to automated outreach in a single session—without juggling spreadsheets or external tools.

Ready to run this sequence? Get started with Origami and turn your prospect list into real conversations.